Home › Compare › MTST vs NOBL

MTST vs NOBL: Dividend Comparison 2026

MTST yields 333333.33% · NOBL yields 2.17%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTST wins by $8.099219044190773e+31M in total portfolio value
10 years
MTST
MTST
● Live price
333333.33%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.099219044190773e+31M
Annual income
$80,944,421,463,343,720,000,000,000,000,000,000,000.00
Full MTST calculator →
NOBL
NOBL
● Live price
2.17%
Share price
$104.67
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.78
Full NOBL calculator →

Portfolio growth — MTST vs NOBL

📍 MTST pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTSTNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTST + NOBL cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MTST pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTST
Annual income on $10K today (after 15% tax)
$28,333,333.33/yr
After 10yr DRIP, annual income (after tax)
$68,802,758,243,842,160,000,000,000,000,000,000,000.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$184.52/yr
After 10yr DRIP, annual income (after tax)
$212.31/yr
At 15% tax rate, MTST beats the other by $68,802,758,243,842,160,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTST + NOBL for your $10,000?

MTST: 50%NOBL: 50%
100% NOBL50/50100% MTST
Portfolio after 10yr
$4.0496095220953863e+31M
Annual income
$40,472,210,731,671,860,000,000,000,000,000,000,000.00/yr
Blended yield
99.94%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTST buys
0
NOBL buys
0
No recent congressional trades found for MTST or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTSTNOBL
Forward yield333333.33% ✓2.17%
Annual dividend / share$2.00$2.27 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$8.099219044190773e+31M$22.9K ✓
Annual income after 10y$80,944,421,463,343,720,000,000,000,000,000,000,000.00 ✓$249.78
Total dividends collected$8.098906375781879e+31M ✓$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MTST vs NOBL ($10,000, DRIP)

YearMTST PortfolioMTST Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$33,344,033$33,333,333.33$10,917$217.08+$33.33M → MTST
2$103,911,171,366$103,875,493,250.26$11,903$221.48+$103911.16M → MTST
3$302,644,656,190,810$302,533,471,237,448.00$12,962$225.68+$302644656.18M → MTST
4$823,817,797,451,856,400$823,493,967,669,732,100.00$14,099$229.68+$823817797451.84M → MTST
5$2,095,836,995,961,804,000,000$2,094,955,510,918,530,000,000.00$15,319$233.49+$2095836995961804.00M → MTST
6$4,983,251,920,823,462,000,000,000$4,981,009,375,237,783,000,000,000.00$16,628$237.10+$4983251920823461888.00M → MTST
7$11,073,835,968,753,321,000,000,000,000$11,068,503,889,198,040,000,000,000,000.00$18,033$240.53+$1.1073835968753322e+22M → MTST
8$22,999,277,308,531,336,000,000,000,000,000$22,987,428,304,044,770,000,000,000,000,000.00$19,539$243.78+$2.2999277308531335e+25M → MTST
9$44,643,905,199,991,210,000,000,000,000,000,000$44,619,295,973,271,085,000,000,000,000,000,000.00$21,154$246.86+$4.464390519999121e+28M → MTST
10$80,992,190,441,907,720,000,000,000,000,000,000,000$80,944,421,463,343,720,000,000,000,000,000,000,000.00$22,884$249.78+$8.099219044190773e+31M → MTST

MTST vs NOBL: Complete Analysis 2026

MTST — Stock

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company's therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.

Full MTST Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this MTST vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTST vs SCHDMTST vs JEPIMTST vs OMTST vs KOMTST vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.